3 Safest Stocks to Buy Now
With the S&P 500 now in correction and stocks selling…
Sell
38
VTAK Quote, Financials, Valuation and Earnings
Last price:
$0.36
Seasonality move
:
-35.2%
Day range:
$0.36 - $0.40
52-week range:
$0.30 - $8.40
Dividend yield:
0%
P/E ratio:
0.42x
P/S ratio:
0.98x
P/B ratio:
0.23x
Volume:
181.6K
Avg. volume:
162.1K
1-year change:
-93.7%
Market cap:
$2.9M
Revenue:
$442K
EPS (TTM):
$0.88
Analysts' Opinion
-
Consensus RatingNo consensus rating exists at this time due to lack of analyst coverage.
-
Price Target UpsideNo price target exists because of limited analyst coverage.
-
Price Target DownsideSimilarly, at this time, analysts have not provided a price target so downside risk can't be assessed accurately at this time.
Fair Value
-
According to the consensus of 0 analysts, Catheter Precision has 444.66% upside to fair value with a price target of -- per share.
VTAK vs. S&P 500
-
Over the past 5 trading days, Catheter Precision has overperformed the S&P 500 by 15.16% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Catheter Precision does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Catheter Precision revenues have been falling on a year-over-year basis for 3 quarters in a row. In the most recent quarter Catheter Precision reported revenues of $96K.
Earnings Growth
-
Catheter Precision has grown year-over-year earnings for 0 quarters straight. In the most recent quarter Catheter Precision reported earnings per share of -$2.01.
Enterprise value:
3.4M
EV / Invested capital:
--
Price / LTM sales:
0.98x
EV / EBIT:
0.08x
EV / Revenue:
8.57x
PEG ratio (5yr expected):
--
EV / Free cash flow:
-0.41x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
0.08x
Gross Profit (TTM):
$361K
Return On Assets:
-40.39%
Net Income Margin (TTM):
-2928.32%
Return On Equity:
-65.84%
Return On Invested Capital:
-63.93%
Operating Margin:
-2978.13%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Income Statement | ||||||
| Revenue | -- | -- | $399K | $133K | $96K | |
| Gross Profit | -$489K | $291K | $361K | $127K | $86K | |
| Operating Income | -$22.9M | -$22.7M | -$10.8M | -$2.7M | -$2.9M | |
| EBITDA | -$22.2M | -$19.9M | $45.4M | -$1.4M | -$3.6M | |
| Diluted EPS | -$926.40 | -$290.03 | $0.88 | -$2.83 | -$2.01 | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $37.2M | $22.8M | $15.5M | $5.8M | $1.7M | |
| Total Assets | $43.5M | $27.1M | $17.5M | $32.9M | $26.7M | |
| Current Liabilities | $8M | $3.5M | $3.2M | $2M | $2.6M | |
| Total Liabilities | $12.9M | $5.5M | $5M | $11M | $13.9M | |
| Total Equity | $30.5M | $21.5M | $12.5M | $21.9M | $12.8M | |
| Total Debt | $2.3M | -- | -- | -- | $1.7M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -$25.3M | -$21.8M | -$8.3M | -$1.8M | -$2.8M | |
| Cash From Investing | -$1K | -$22K | -$85K | -$1K | -- | |
| Cash From Financing | $18.3M | $13.7M | $4.1M | -- | $4M | |
| Free Cash Flow | -$25.3M | -$21.8M | -$8.4M | -$1.8M | -$2.8M | |
VTAK
Sector
Market Cap
$2.9M
$38.4M
Price % of 52-Week High
4.37%
45.53%
Dividend Yield
0%
0%
Shareholder Yield
-217.12%
-0.78%
1-Year Price Total Return
-93.7%
-39.05%
Beta (5-Year)
-0.541
0.774
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Technicals
8-day SMA
Buy
Level
$0.34
200-day SMA
Sell
Level
$1.54
Bollinger Bands (100)
Sell
Level
0.32 - 0.56
Chaikin Money Flow
Sell
Level
-172.3M
20-day SMA
Buy
Level
$0.35
Relative Strength Index (RSI14)
Buy
Level
51.11
ADX Line
Buy
Level
12.83
Williams %R
Neutral
Level
-41.9666
50-day SMA
Sell
Level
$0.41
MACD (12, 26)
Sell
Level
-0.01
25-day Aroon Oscillator
Sell
Level
-60
On Balance Volume
Neutral
Level
206.9M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (-14.3052)
Sell
CA Score
(Annual)
Level (-3.0722)
--
Beneish M-Score
(Annual)
Level (--)
Sell
Momentum Score
Level (1)
Sell
Ohlson Score
Level (20.7571)
Buy
Piotroski F Score
(Annual)
Level (4)
Sell
Quality Ratio Score
Level (1)
Sell
Fundamental Score
Level (1)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Catheter Precision Inc is engaged in design, manufacture and sale of new and innovative medical technologies primarily focused in the field of cardiac electrophysiology, or EP. The Company’s primary product is the View into Ventricular Onset System (VIVO or VIVO System) which is a non-invasive imaging system that offers 3D cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures. The VIVO system has achieved a CE Mark allowing it to be commercialized in the European Union and has been placed at several hospitals in Europe. Its newest product, the Surgical Vessel Closing Pressure Device (LockeT), is a suture retention device indicated for wound healing by distributing suture tension.
Stock Forecast FAQ
In the current month, VTAK has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The VTAK average analyst price target in the past 3 months is --.
-
Where Will Catheter Precision Stock Be In 1 Year?
According to analysts, the consensus estimate is that Catheter Precision share price will rise to -- per share over the next 12 months.
-
What Do Analysts Say About Catheter Precision?
Analysts are divided on their view about Catheter Precision share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Catheter Precision is a Sell and believe this share price will drop from its current level to --.
-
What Is Catheter Precision's Price Target?
The price target for Catheter Precision over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is VTAK A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Catheter Precision is a --. 0 of 0 analysts rate the stock a -- at this time.
-
How Can I Buy Shares Of VTAK?
You can purchase shares of Catheter Precision via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Catheter Precision shares.
-
What Is The Catheter Precision Share Price Today?
Catheter Precision was last trading at $0.36 per share. This represents the most recent stock quote for Catheter Precision. Yesterday, Catheter Precision closed at $0.37 per share.
-
How To Buy Catheter Precision Stock Online?
In order to purchase Catheter Precision stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Tesla Stock: The Bear Case
The recent stock market drop has been a punishing time…
Is VUG a Good ETF to Buy?
For the last few years, earnings growth from the tech…
Stock Ideas
Sell
46
Is AAPL Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 36x
Sell
48
Is MSFT Stock a Buy?
Market Cap: $2.8T
P/E Ratio: 32x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $2.8T
P/E Ratio: 39x
Alerts
Sell
50
TREE alert for Mar 13
LendingTree [TREE] is up 1.53% over the past day.
Buy
57
INOD alert for Mar 13
Innodata [INOD] is down 7.4% over the past day.
Sell
40
VIST alert for Mar 13
Vista Energy SAB de CV [VIST] is up 0.36% over the past day.
